HCPLive Network

Study Finds Increase in Number of ER Visits from Misuse of ADHD Stimulants by Young Adults

 
TUESDAY, Jan. 29 (HealthDay News) -- From 2005 to 2010, there was an increase in the number of emergency department visits involving attention-deficit/hyperactivity disorder (ADHD) stimulant medications, with the number of visits increasing significantly among adults aged 18 years or older, according to a study published online Jan. 24 by the Substance Abuse and Mental Health Services Administration (SAMHSA).

Researchers from SAMHSA in Rockville, Md., used data from the Drug Abuse Warning Network surveillance system to examine trends in emergency department visits involving ADHD stimulant medications from 2005 to 2010.

The researchers found that, from 2005 to 2010, there was an increase in the number of emergency department visits involving ADHD stimulant medications, from 13,379 to 31,244 visits. The increase was significant among adults aged 18 years and older, but no significant increases were observed for children (aged younger than 18). The number of emergency department visits related to ADHD stimulant medications that involved nonmedical use increased from 5,212 in 2005 to 15,585 in 2010. During the same period, the number of visits involving adverse reactions increased from 5,085 to 9,181. In 45 percent of all emergency department visits involving ADHD stimulant medications, other pharmaceutical drugs were involved, while illicit drugs and alcohol were involved in 21 and 19 percent, respectively.

"This report shows that emergency department visits for nonmedical use have not increased among children and adolescents, but they have increased among adults aged 18 or older," the authors write. "This suggests a need for increased attention toward efforts to prevent diversion and misuse among adults."
 

More Information

 
Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Researchers at Hong Kong University and the Wellcome Trust Sanger Institute have identified a link between the influenza A viruses’ genetic diversity and severity of the infection.
Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.
Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
The immune system is the new focus of much work on traumatic brain injury (TBI). In a challenge to the paradigm that the blood brain barrier prevents harmful leukocytes from entering the brain, a Texas team tried to neutralize the impact of these cells. Peripheral lymphocytes are activated after TBI. They may then act as potential antigen presenting cells and get into the brain, causing cells there to degenerate.
Black women undergoing in vitro fertilization are only about half as likely as white women to become pregnant, and the racial disparity persists even when donor eggs are used. These findings are being presented at the annual meeting of the American Society for Reproductive Medicine, held from Oct. 18 to 22 in Honolulu.
Hospital conversion to for-profit status is associated with improvements in financial margins, but has no effect on process quality metrics or mortality rates, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association
Drinking sugar-sweetened sodas may affect cellular aging by shortening telomere length, according to research published online Oct. 16 in the American Journal of Public Health.
More Reading